Form 4 Tracker
Tarsus Pharmaceuticals, Inc.
TARS

43 insider filings · Latest: Jun 25, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Mar 19, 2025Mar 19 7:12 PMMottiwala Aziz
Proposed Sale
3,557$47.40$168.6K

View →

Mar 18, 2025Mar 18 8:31 PMNeervannan Seshadri
Proposed Sale
2,605$46.28$120.6K

View →

Mar 18, 2025Mar 18 8:26 PMWahl Bryan
Proposed Sale
3,341$46.28$154.6K

View →

Mar 18, 2025Mar 18 8:26 PMMottiwala Aziz
Proposed Sale
3,643$46.28$168.6K

View →

Mar 18, 2025Mar 18 8:20 PMWhitfield Dianne C.
Proposed Sale
2,315$46.28$107.1K

View →

Mar 18, 2025Mar 18 8:15 PMAzamian Bobak R.
Proposed Sale
7,131$46.28$330.1K

View →

Mar 18, 2025Mar 18 8:12 PMFarrow Jeffrey S
Proposed Sale
1,284$46.28$59.4K

View →

← Previous

Page 5 of 5

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 15, 2026Mar 17 8:24 PMBobak R. AzamianDirector, President/CEO and Board Chair
Option Exercise
66,27444,634(D)

View →

Mar 15, 2026Mar 17 8:20 PMElizabeth Yeu LinChief Medical Officer
Option Exercise
2,5117,534(D)

View →

Mar 5, 2026Mar 9 8:06 PMBryan WahlGeneral Counsel
Grant/Award
44,471$74.9017,161(D)

View →

Mar 5, 2026Mar 9 8:06 PMJeffrey S FarrowChief Financial Officer and Chief Strategy Officer
Grant/Award
50,030$74.9019,306(D)

View →

Mar 5, 2026Mar 9 8:06 PMAziz MottiwalaChief Commercial Officer
Grant/Award
50,030$74.9019,306(D)

View →

Mar 5, 2026Mar 9 8:06 PMSeshadri NeervannanChief Operating Officer
Grant/Award
44,471$74.9017,161(D)

View →

Mar 5, 2026Mar 9 8:06 PMDianne C. WhitfieldChief Human Resources Officer
Grant/Award
44,471$74.9017,161(D)

View →

Mar 5, 2026Mar 9 8:06 PMElizabeth Yeu LinChief Medical Officer
Grant/Award
44,471$74.9017,161(D)

View →

Mar 5, 2026Mar 9 8:06 PMBobak R. AzamianDirector, President/CEO and Board Chair
Grant/Award
157,499$74.9060,776(D)

View →

Feb 18, 2026Feb 20 9:35 PMI E Pyott DavidDirector
Grant/Award
9,622$63.273,729(D)

View →

← Previous

Page 2 of 2